AstraZeneca $1.5B Cancer Investment, Aquamarine Light Show Over Spain, Neuralink approved for 2nd implant, Spinal Cord Recovery Breakthrough, and more...
MP3•Episode home
Manage episode 419367813 series 3533034
Content provided by brief.news. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by brief.news or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
(0:10): AstraZeneca to Invest $1.5B in Singapore for Revolutionary Cancer Drug Manufacturing Facility
(1:43): Stunning Aquamarine Light Show Over Spain and Portugal Highlights Urgency for Better Space Object Detection
(3:29): Neuralink Gains FDA Nod for Second Human Brain Implant, Targets 10 Patients by Year-End
(5:31): Breakthrough Electrical Stimulation Device Offers New Hope for Spinal Cord Injury Recovery
(8:07): Groundbreaking Research Reveals Superheated Core of 'Warm Neptune' WASP-107 b, Challenging Planet Formation Theories
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Quartz
…
continue reading
(1:43): Stunning Aquamarine Light Show Over Spain and Portugal Highlights Urgency for Better Space Object Detection
(3:29): Neuralink Gains FDA Nod for Second Human Brain Implant, Targets 10 Patients by Year-End
(5:31): Breakthrough Electrical Stimulation Device Offers New Hope for Spinal Cord Injury Recovery
(8:07): Groundbreaking Research Reveals Superheated Core of 'Warm Neptune' WASP-107 b, Challenging Planet Formation Theories
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Quartz
197 episodes